AG
TNDM icon

Aperio Group’s Tandem Diabetes Care TNDM Stock Holding History

Aperio Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$265K Sell
2,771
-671
-19% -$69.2K ﹤0.01% 2229
2020
Q3 		$391K Buy
3,442
+192
+6% +$20.2K ﹤0.01% 1952
2020
Q2 		$321K Buy
+3,250
New +$259K ﹤0.01% 1994
2019
Q4 		– Sell
-3,428
Closed -$202K – 2341
2019
Q3 		$202K Buy
3,428
+787
+30% +$50.2K ﹤0.01% 2165
2019
Q2 		$170K Buy
+2,641
New +$170K ﹤0.01% 2231

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aperio Group's TNDM Position: Q4 2020 in Review

Aperio Group reduced its Tandem Diabetes Care (TNDM) stake by 19% in Q4 2020, selling an estimated $69.2K and leaving 2,771 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Aperio Group first reported a position in TNDM in Q2 2019 and has held it in 5 quarters since. The position peaked at $391K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Aperio Group held 2,771 shares of Tandem Diabetes Care worth $265K as of Q4 2020.
  • Aperio Group sold 671 Tandem Diabetes Care shares in Q4 2020, an estimated $69.2K.
  • Tandem Diabetes Care made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2229 holding.
  • Aperio Group first reported a position in Tandem Diabetes Care in Q2 2019 and has held it in 5 quarters since.
  • Aperio Group's Tandem Diabetes Care position peaked at $391K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.